2015Jiepouxue yanjiuRequires access

Effect of inhibitor of cyclooxygenase-2 on the expression of VEGF in A549 cell lines of non-sman cell lung cancers

Tong We

Open publisher page 0 citations

Abstract

Objective To study the effect of inhibitor of cyclooxygenase-2 on the expression of vascular endothelial growth factor(VEGF)in A549 cell lines of non-sman cell lung cancers. Methods The proliferation of A549 lung carcinoma cells was measured by MTT assay After A549 cells were treated with different dose celecoxib; After A549 cells were treated with celecoxib 50μmol/L for 48 h, the level of VEGF m RNA was detected RT-PCR, and the expressions of VEGF protein was detected by western blot method. Results Celecoxib could inhibit the proliferation of A549 cell by a time-and dose-dependent manner. Compared with control group, the level of VEGF m RNA was decreased significantly detected by RT-PCR after A549 cells were trealed with celecoxib 50μmol·L-1for 48 h, P0.01 and the expression of VEGF protein was decreased significantly detected by western blot method, P0.01.Conclusion celecoxib might inhibite the proliferation of A549 lung carcinoma cells by regulating the expressions of VEGF.

About this research paper

What this paper is about

Objective To study the effect of inhibitor of cyclooxygenase-2 on the expression of vascular endothelial growth factor(VEGF)in A549 cell lines of non-sman cell lung cancers. Methods The proliferation of A549 lung carcinoma cells was measured by MTT assay After A549 cells were treated with different dose celecoxib; After A549 cells were treated with celecoxib 50μmol/L for 48 h, the level of VEGF m RNA was detected RT-PCR, and the expressions of VEGF protein was detected by western blot method. Results Celecoxib could inhibit the proliferation of A549 cell by a time-and dose-dependent manner. Compared with control group, the level of VEGF m RNA was decreased significantly detected by RT-PCR after A549 cells were trealed with celecoxib 50μmol·L-1for 48 h, P0.01 and the expression of VEGF protein was decreased significantly detected by western blot method, P0.01.Conclusion celecoxib might inhibite the proliferation of A549 lung carcinoma cells by regulating the expressions of VEGF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effect of inhibitor of cyclooxygenase-2 on the expression of vascular endothelial growth factor(VEGF)in A549 cell lines of non-sman cell lung cancers. Methods The proliferation of A549 lung carcinoma cells was measured by MTT assay After A549 cells were treated with different dose celecoxib; After A549 cells were treated with celecoxib 50μmol/L for 48 h, the level of VEGF m RNA was detected RT-PCR, and the expressions of VEGF protein was detected by western blot method. Results Celecoxib could inhibit the proliferation of A549 cell by a time-and dose-dependent manner. Compared with control group, the level of VEGF m RNA was decreased significantly detected by RT-PCR after A549 cells were trealed with celecoxib 50μmol·L-1for 48 h, P0.01 and the expression of VEGF protein was decreased significantly detected by western blot method, P0.01.Conclusion celecoxib might inhibite the proliferation of A549 lung carcinoma cells by regulating the expressions of VEGF.

Key concepts: Celecoxib, A549 cell, Western blot, Vascular endothelial growth factor, Cell growth, Molecular biology, Cyclooxygenase, Cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of inhibitor of cyclooxygenase-2 on the expression of VEGF in A549 cell lines of non-sman cell lung cancers — Research Paper | ScholarLens